| 1 |
35138562 | Characterization of vitamin D metabolism in active acromegaly in the setting of bolus (150,000 IU) cholecalciferol treatment. | 2022 May |
1 |
| 2 |
34873873 | Vitamin D binding protein greatly improves bioactivity but is not essential for orally administered vitamin D. | 2021 Dec |
6 |
| 3 |
30067874 | Effect of vitamin D supplementation on free and total vitamin D: A comparison of Asians and Caucasians. | 2019 Jan |
1 |
| 4 |
28095044 | VITAMIN D BINDING PROTEIN AND 25-HYDROXYVITAMIN D LEVELS: EMERGING CLINICAL APPLICATIONS. | 2017 May |
1 |
| 5 |
28116494 | Use of surface plasmon resonance in the binding study of vitamin D, metabolites and analogues with vitamin D binding protein. | 2017 Apr |
3 |
| 6 |
28257826 | Structural aspects of Vitamin D endocrinology. | 2017 Sep 15 |
1 |
| 7 |
25716812 | [Current Topics on Vitamin D. Protein interaction and biological action of active vitamin D compounds]. | 2015 Mar |
1 |
| 8 |
23339019 | Vitamin D-binding protein in cerebrospinal fluid is associated with multiple sclerosis progression. | 2013 Jun |
1 |
| 9 |
23556437 | Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D₃ or D₂supplementation. | 2013 Apr 4 |
1 |
| 10 |
11799400 | A structural basis for the unique binding features of the human vitamin D-binding protein. | 2002 Feb |
4 |
| 11 |
7786034 | 25-Hydroxy[26,27-methyl-3H]vitamin D3-3 beta-(1,2-epoxypropyl)ether: an affinity labeling reagent for human vitamin D-binding protein. | 1995 Jun 1 |
2 |
| 12 |
8390483 | Human plasma transport of vitamin D after its endogenous synthesis. | 1993 Jun |
2 |
| 13 |
1331703 | Elevation of blood vitamin D2 levels does not impede the release of vitamin D3 from the skin. | 1992 Nov |
2 |
| 14 |
90502 | Quantitative studies of the interaction of cholecalciferol ((vitamin D3) and its metabolites with different genetic variants of the serum binding protein for these sterols. | 1979 May 1 |
4 |